Loading…

Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune response

Loss of HLA class I expression on tumor cells is a frequent event as an immune escape mechanism. Seven different altered HLA phenotypes have been defined in tumors. Various molecular mechanisms have been described as responsible for HLA class I loss. HLA class I expression alterations occur successi...

Full description

Saved in:
Bibliographic Details
Published in:International journal of cancer 2007-11, Vol.121 (9), p.2023-2030
Main Authors: Paco, Laura, Garcia‐Lora, Angel Miguel, Casares, Carlos, Cabrera, Carmen, Algarra, Ignacio, Collado, Antonia, Maleno, Isabel, Garrido, Federico, Lopez‐Nevot, Miguel Angel
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4195-581c97746adcbe7f133fb62cefdcaa37c2d2e21105cbfba9026cd098f160e5cc3
cites cdi_FETCH-LOGICAL-c4195-581c97746adcbe7f133fb62cefdcaa37c2d2e21105cbfba9026cd098f160e5cc3
container_end_page 2030
container_issue 9
container_start_page 2023
container_title International journal of cancer
container_volume 121
creator Paco, Laura
Garcia‐Lora, Angel Miguel
Casares, Carlos
Cabrera, Carmen
Algarra, Ignacio
Collado, Antonia
Maleno, Isabel
Garrido, Federico
Lopez‐Nevot, Miguel Angel
description Loss of HLA class I expression on tumor cells is a frequent event as an immune escape mechanism. Seven different altered HLA phenotypes have been defined in tumors. Various molecular mechanisms have been described as responsible for HLA class I loss. HLA class I expression alterations occur successively and unpredictably during tumor progression in vivo and immunoselection has been implicated in this process. We present an experimental xenograft model in which melanoma cell line Ando‐2 injected into athymic nude mice lost total surface HLA class I expression and exhibited HLA class II cell surface expression. A strong down‐regulation of HLA class I expression and de novo HLA class II expression were also found when Ando‐2 melanoma cells were injected into SCID‐Beige mice. These phenomena were reproducible and were only observed in local growth in nude or SCID‐Beige mice and not in vitro after multiple passages. HLA class I surface expression was recovered after IFN‐γ treatment, indicating regulatory defects. The mechanism implicated in loss of HLA class I molecule expression were a down‐regulation of different components of antigen processing machinery and HLA class I heavy chains. These data suggest that HLA class I alterations can also occur in absence of autologous adaptive immune response. This is a good experimental in vivo model to study the relationship between tumor progression and HLA class I alterations. © 2007 Wiley‐Liss, Inc.
doi_str_mv 10.1002/ijc.22925
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68298971</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20571056</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4195-581c97746adcbe7f133fb62cefdcaa37c2d2e21105cbfba9026cd098f160e5cc3</originalsourceid><addsrcrecordid>eNqFkd9qFDEUxoModq1e-AKSG4VeTJtkNpnJZVnUrix4U6-HM5mTmpI_azJD7SP0rc26C70SIZAc8sv3nZyPkPecXXLGxJW7N5dCaCFfkBVnumuY4PIlWdU71nS8VWfkTSn3jHEu2fo1OeOdElyJfkWebtMMnvpUCk2W3uyuqfFQiy3F3_uMpbgUaV1AA3qIKQA16OsLF5GCnTHTu5we5p_URRqXCWlwBg8FjAVjPVZZWObk011aCoU4u3kJKVMXwlI1qsc-xYJvySsLvuC7035Ofnz5fLu5aXbfv24317vGrLmWjey50V23VjCZETvL29aOShi0kwFoOyMmgYJzJs1oR9BMKDMx3VuuGEpj2nPy6ai7z-nXgmUegiuHL0HE2uCgeqF7Xaf2P1Aw2VUbVcGLI2hyHWNGO-yzC5AfB86GQ0BDDWj4G1BlP5xElzHg9EyeEqnAxxMAxYC3GaJx5ZnTTLFeHrirI_fgPD7-23HYftscrf8AXV6o4Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20571056</pqid></control><display><type>article</type><title>Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune response</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><creator>Paco, Laura ; Garcia‐Lora, Angel Miguel ; Casares, Carlos ; Cabrera, Carmen ; Algarra, Ignacio ; Collado, Antonia ; Maleno, Isabel ; Garrido, Federico ; Lopez‐Nevot, Miguel Angel</creator><creatorcontrib>Paco, Laura ; Garcia‐Lora, Angel Miguel ; Casares, Carlos ; Cabrera, Carmen ; Algarra, Ignacio ; Collado, Antonia ; Maleno, Isabel ; Garrido, Federico ; Lopez‐Nevot, Miguel Angel</creatorcontrib><description>Loss of HLA class I expression on tumor cells is a frequent event as an immune escape mechanism. Seven different altered HLA phenotypes have been defined in tumors. Various molecular mechanisms have been described as responsible for HLA class I loss. HLA class I expression alterations occur successively and unpredictably during tumor progression in vivo and immunoselection has been implicated in this process. We present an experimental xenograft model in which melanoma cell line Ando‐2 injected into athymic nude mice lost total surface HLA class I expression and exhibited HLA class II cell surface expression. A strong down‐regulation of HLA class I expression and de novo HLA class II expression were also found when Ando‐2 melanoma cells were injected into SCID‐Beige mice. These phenomena were reproducible and were only observed in local growth in nude or SCID‐Beige mice and not in vitro after multiple passages. HLA class I surface expression was recovered after IFN‐γ treatment, indicating regulatory defects. The mechanism implicated in loss of HLA class I molecule expression were a down‐regulation of different components of antigen processing machinery and HLA class I heavy chains. These data suggest that HLA class I alterations can also occur in absence of autologous adaptive immune response. This is a good experimental in vivo model to study the relationship between tumor progression and HLA class I alterations. © 2007 Wiley‐Liss, Inc.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/ijc.22925</identifier><identifier>PMID: 17621628</identifier><identifier>CODEN: IJCNAW</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Animals ; APM down‐regulation ; autologous immune response ; Biological and medical sciences ; Cell Line, Tumor ; Cell Membrane - metabolism ; Dermatology ; Disease Progression ; Down-Regulation ; Gene Expression Regulation, Neoplastic ; Genome - genetics ; Histocompatibility Antigens Class I - genetics ; Histocompatibility Antigens Class I - immunology ; Histocompatibility Antigens Class I - metabolism ; Histocompatibility Antigens Class II - genetics ; Histocompatibility Antigens Class II - immunology ; Histocompatibility Antigens Class II - metabolism ; HLA alterations ; Medical sciences ; Melanoma - genetics ; Melanoma - immunology ; Melanoma - metabolism ; Melanoma - pathology ; Mice ; Mice, Nude ; Neoplasm Transplantation ; nude mice ; RNA, Messenger - genetics ; tumor cell ; Tumors ; Tumors of the skin and soft tissue. Premalignant lesions ; Xenograft model</subject><ispartof>International journal of cancer, 2007-11, Vol.121 (9), p.2023-2030</ispartof><rights>Copyright © 2007 Wiley‐Liss, Inc.</rights><rights>2007 INIST-CNRS</rights><rights>Copyright (c) 2007 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4195-581c97746adcbe7f133fb62cefdcaa37c2d2e21105cbfba9026cd098f160e5cc3</citedby><cites>FETCH-LOGICAL-c4195-581c97746adcbe7f133fb62cefdcaa37c2d2e21105cbfba9026cd098f160e5cc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19060858$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17621628$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Paco, Laura</creatorcontrib><creatorcontrib>Garcia‐Lora, Angel Miguel</creatorcontrib><creatorcontrib>Casares, Carlos</creatorcontrib><creatorcontrib>Cabrera, Carmen</creatorcontrib><creatorcontrib>Algarra, Ignacio</creatorcontrib><creatorcontrib>Collado, Antonia</creatorcontrib><creatorcontrib>Maleno, Isabel</creatorcontrib><creatorcontrib>Garrido, Federico</creatorcontrib><creatorcontrib>Lopez‐Nevot, Miguel Angel</creatorcontrib><title>Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune response</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>Loss of HLA class I expression on tumor cells is a frequent event as an immune escape mechanism. Seven different altered HLA phenotypes have been defined in tumors. Various molecular mechanisms have been described as responsible for HLA class I loss. HLA class I expression alterations occur successively and unpredictably during tumor progression in vivo and immunoselection has been implicated in this process. We present an experimental xenograft model in which melanoma cell line Ando‐2 injected into athymic nude mice lost total surface HLA class I expression and exhibited HLA class II cell surface expression. A strong down‐regulation of HLA class I expression and de novo HLA class II expression were also found when Ando‐2 melanoma cells were injected into SCID‐Beige mice. These phenomena were reproducible and were only observed in local growth in nude or SCID‐Beige mice and not in vitro after multiple passages. HLA class I surface expression was recovered after IFN‐γ treatment, indicating regulatory defects. The mechanism implicated in loss of HLA class I molecule expression were a down‐regulation of different components of antigen processing machinery and HLA class I heavy chains. These data suggest that HLA class I alterations can also occur in absence of autologous adaptive immune response. This is a good experimental in vivo model to study the relationship between tumor progression and HLA class I alterations. © 2007 Wiley‐Liss, Inc.</description><subject>Animals</subject><subject>APM down‐regulation</subject><subject>autologous immune response</subject><subject>Biological and medical sciences</subject><subject>Cell Line, Tumor</subject><subject>Cell Membrane - metabolism</subject><subject>Dermatology</subject><subject>Disease Progression</subject><subject>Down-Regulation</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Genome - genetics</subject><subject>Histocompatibility Antigens Class I - genetics</subject><subject>Histocompatibility Antigens Class I - immunology</subject><subject>Histocompatibility Antigens Class I - metabolism</subject><subject>Histocompatibility Antigens Class II - genetics</subject><subject>Histocompatibility Antigens Class II - immunology</subject><subject>Histocompatibility Antigens Class II - metabolism</subject><subject>HLA alterations</subject><subject>Medical sciences</subject><subject>Melanoma - genetics</subject><subject>Melanoma - immunology</subject><subject>Melanoma - metabolism</subject><subject>Melanoma - pathology</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Neoplasm Transplantation</subject><subject>nude mice</subject><subject>RNA, Messenger - genetics</subject><subject>tumor cell</subject><subject>Tumors</subject><subject>Tumors of the skin and soft tissue. Premalignant lesions</subject><subject>Xenograft model</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkd9qFDEUxoModq1e-AKSG4VeTJtkNpnJZVnUrix4U6-HM5mTmpI_azJD7SP0rc26C70SIZAc8sv3nZyPkPecXXLGxJW7N5dCaCFfkBVnumuY4PIlWdU71nS8VWfkTSn3jHEu2fo1OeOdElyJfkWebtMMnvpUCk2W3uyuqfFQiy3F3_uMpbgUaV1AA3qIKQA16OsLF5GCnTHTu5we5p_URRqXCWlwBg8FjAVjPVZZWObk011aCoU4u3kJKVMXwlI1qsc-xYJvySsLvuC7035Ofnz5fLu5aXbfv24317vGrLmWjey50V23VjCZETvL29aOShi0kwFoOyMmgYJzJs1oR9BMKDMx3VuuGEpj2nPy6ai7z-nXgmUegiuHL0HE2uCgeqF7Xaf2P1Aw2VUbVcGLI2hyHWNGO-yzC5AfB86GQ0BDDWj4G1BlP5xElzHg9EyeEqnAxxMAxYC3GaJx5ZnTTLFeHrirI_fgPD7-23HYftscrf8AXV6o4Q</recordid><startdate>20071101</startdate><enddate>20071101</enddate><creator>Paco, Laura</creator><creator>Garcia‐Lora, Angel Miguel</creator><creator>Casares, Carlos</creator><creator>Cabrera, Carmen</creator><creator>Algarra, Ignacio</creator><creator>Collado, Antonia</creator><creator>Maleno, Isabel</creator><creator>Garrido, Federico</creator><creator>Lopez‐Nevot, Miguel Angel</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20071101</creationdate><title>Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune response</title><author>Paco, Laura ; Garcia‐Lora, Angel Miguel ; Casares, Carlos ; Cabrera, Carmen ; Algarra, Ignacio ; Collado, Antonia ; Maleno, Isabel ; Garrido, Federico ; Lopez‐Nevot, Miguel Angel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4195-581c97746adcbe7f133fb62cefdcaa37c2d2e21105cbfba9026cd098f160e5cc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Animals</topic><topic>APM down‐regulation</topic><topic>autologous immune response</topic><topic>Biological and medical sciences</topic><topic>Cell Line, Tumor</topic><topic>Cell Membrane - metabolism</topic><topic>Dermatology</topic><topic>Disease Progression</topic><topic>Down-Regulation</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Genome - genetics</topic><topic>Histocompatibility Antigens Class I - genetics</topic><topic>Histocompatibility Antigens Class I - immunology</topic><topic>Histocompatibility Antigens Class I - metabolism</topic><topic>Histocompatibility Antigens Class II - genetics</topic><topic>Histocompatibility Antigens Class II - immunology</topic><topic>Histocompatibility Antigens Class II - metabolism</topic><topic>HLA alterations</topic><topic>Medical sciences</topic><topic>Melanoma - genetics</topic><topic>Melanoma - immunology</topic><topic>Melanoma - metabolism</topic><topic>Melanoma - pathology</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Neoplasm Transplantation</topic><topic>nude mice</topic><topic>RNA, Messenger - genetics</topic><topic>tumor cell</topic><topic>Tumors</topic><topic>Tumors of the skin and soft tissue. Premalignant lesions</topic><topic>Xenograft model</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Paco, Laura</creatorcontrib><creatorcontrib>Garcia‐Lora, Angel Miguel</creatorcontrib><creatorcontrib>Casares, Carlos</creatorcontrib><creatorcontrib>Cabrera, Carmen</creatorcontrib><creatorcontrib>Algarra, Ignacio</creatorcontrib><creatorcontrib>Collado, Antonia</creatorcontrib><creatorcontrib>Maleno, Isabel</creatorcontrib><creatorcontrib>Garrido, Federico</creatorcontrib><creatorcontrib>Lopez‐Nevot, Miguel Angel</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Paco, Laura</au><au>Garcia‐Lora, Angel Miguel</au><au>Casares, Carlos</au><au>Cabrera, Carmen</au><au>Algarra, Ignacio</au><au>Collado, Antonia</au><au>Maleno, Isabel</au><au>Garrido, Federico</au><au>Lopez‐Nevot, Miguel Angel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune response</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>2007-11-01</date><risdate>2007</risdate><volume>121</volume><issue>9</issue><spage>2023</spage><epage>2030</epage><pages>2023-2030</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><coden>IJCNAW</coden><abstract>Loss of HLA class I expression on tumor cells is a frequent event as an immune escape mechanism. Seven different altered HLA phenotypes have been defined in tumors. Various molecular mechanisms have been described as responsible for HLA class I loss. HLA class I expression alterations occur successively and unpredictably during tumor progression in vivo and immunoselection has been implicated in this process. We present an experimental xenograft model in which melanoma cell line Ando‐2 injected into athymic nude mice lost total surface HLA class I expression and exhibited HLA class II cell surface expression. A strong down‐regulation of HLA class I expression and de novo HLA class II expression were also found when Ando‐2 melanoma cells were injected into SCID‐Beige mice. These phenomena were reproducible and were only observed in local growth in nude or SCID‐Beige mice and not in vitro after multiple passages. HLA class I surface expression was recovered after IFN‐γ treatment, indicating regulatory defects. The mechanism implicated in loss of HLA class I molecule expression were a down‐regulation of different components of antigen processing machinery and HLA class I heavy chains. These data suggest that HLA class I alterations can also occur in absence of autologous adaptive immune response. This is a good experimental in vivo model to study the relationship between tumor progression and HLA class I alterations. © 2007 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>17621628</pmid><doi>10.1002/ijc.22925</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0020-7136
ispartof International journal of cancer, 2007-11, Vol.121 (9), p.2023-2030
issn 0020-7136
1097-0215
language eng
recordid cdi_proquest_miscellaneous_68298971
source Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)
subjects Animals
APM down‐regulation
autologous immune response
Biological and medical sciences
Cell Line, Tumor
Cell Membrane - metabolism
Dermatology
Disease Progression
Down-Regulation
Gene Expression Regulation, Neoplastic
Genome - genetics
Histocompatibility Antigens Class I - genetics
Histocompatibility Antigens Class I - immunology
Histocompatibility Antigens Class I - metabolism
Histocompatibility Antigens Class II - genetics
Histocompatibility Antigens Class II - immunology
Histocompatibility Antigens Class II - metabolism
HLA alterations
Medical sciences
Melanoma - genetics
Melanoma - immunology
Melanoma - metabolism
Melanoma - pathology
Mice
Mice, Nude
Neoplasm Transplantation
nude mice
RNA, Messenger - genetics
tumor cell
Tumors
Tumors of the skin and soft tissue. Premalignant lesions
Xenograft model
title Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune response
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T15%3A14%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Total%20loss%20of%20HLA%20class%20I%20expression%20on%20a%20melanoma%20cell%20line%20after%20growth%20in%20nude%20mice%20in%20absence%20of%20autologous%20antitumor%20immune%20response&rft.jtitle=International%20journal%20of%20cancer&rft.au=Paco,%20Laura&rft.date=2007-11-01&rft.volume=121&rft.issue=9&rft.spage=2023&rft.epage=2030&rft.pages=2023-2030&rft.issn=0020-7136&rft.eissn=1097-0215&rft.coden=IJCNAW&rft_id=info:doi/10.1002/ijc.22925&rft_dat=%3Cproquest_cross%3E20571056%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4195-581c97746adcbe7f133fb62cefdcaa37c2d2e21105cbfba9026cd098f160e5cc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20571056&rft_id=info:pmid/17621628&rfr_iscdi=true